πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Crinetics Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Athira Pharma, Inc.

Athira Pharma, Inc. logo
Market Cap: Lowest
Employees: Low

ATH-1017

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.

Tags: Alzheimer's disease, Parkinson's disease, biopharmaceutical, clinical trials, neurodegeneration

Symbol: ATHA

Recent Price: $0.55

Industry: Biotechnology

CEO: Dr. Mark J. Litton M.B.A., Ph.D.

Sector: Healthcare

Employees: 65

Address: 18706 North Creek Parkway, Bothell, WA 98011

Phone: 425 620 8501

Last updated: 2024-12-31

Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

CY6463

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.

Tags: CNS diseases, CY6463, biopharmaceutical, clinical-stage, therapy development

Symbol: CYCN

Recent Price: $3.45

Industry: Biotechnology

CEO: Dr. Regina Graul Ph.D.

Sector: Healthcare

Employees: 1

Address: 245 First Street, Cambridge, MA 02142

Phone: 857 327 8778

Last updated: 2024-12-31

Kronos Bio, Inc.

Kronos Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

entospletinib (ENTO)

Kronos Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel cancer therapeutics targeting dysregulated transcription factors. It is developing product candidates like entospletinib for acute myeloid leukemia and KB-0742 for MYC-amplified solid tumors.

Tags: acute myeloid leukemia, biopharmaceutical, cancer therapeutics, solid tumors, transcription factors

Symbol: KRON

Recent Price: $0.97

Industry: Biotechnology

CEO: Dr. Norbert W. Bischofberger Ph.D.

Sector: Healthcare

Employees: 58

Address: 1300 South El Camino Real, San Mateo, CA 94402

Phone: 650 781 5200

Last updated: 2024-12-31

Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. logo
Market Cap: Lowest
Employees: Lowest

Therapies for CNS diseases

Pasithea Therapeutics Corp. is a biotechnology company engaged in research and discovery of treatments for psychiatric and neurological disorders. It plans to operate anti-depression clinics and provide business support services, using trained pharmacists to administer intravenous infusions of ketamine. Founded in 2020, the company is based in Miami Beach, Florida.

Tags: CNS diseases, biotechnology, ketamine treatment, neurological disorders, psychiatric disorders

Symbol: KTTA

Recent Price: $2.95

Industry: Biotechnology

CEO: Dr. Tiago Reis Marques M.D., Ph.D.

Sector: Healthcare

Employees: 8

Address: 1111 Lincoln Road, Miami Beach, FL 33139

Phone: 702 514 4174

Last updated: 2024-12-31

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. logo
Market Cap: High
Employees: Low

rusfertide (PTG-300), PN-943, PN-235

Protagonist Therapeutics, Inc. is a biopharmaceutical company that focuses on the discovery and development of peptide-based therapeutic drugs for hematology, blood disorders, and inflammatory and immunomodulatory diseases.

Tags: biopharmaceutical, blood disorders, hematology, immunomodulatory diseases, inflammatory diseases, peptide-based drugs

Symbol: PTGX

Recent Price: $38.51

Industry: Biotechnology

CEO: Dr. Dinesh V. Patel Ph.D.

Sector: Healthcare

Employees: 125

Address: 7707 Gateway Boulevard, Newark, CA 94560-1160

Phone: 510 474 0170

Last updated: 2024-12-31

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

PYX-106, PYX-102, PYX-201, PYX-202, PYX-203

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.

Tags: antibody drug conjugate, biopharmaceutical, cancer therapy, immune-oncology, solid tumors

Symbol: PYXS

Recent Price: $1.56

Industry: Biotechnology

CEO: Dr. Lara S. Sullivan M.D., MBA

Sector: Healthcare

Employees: 55

Address: 35 Cambridgepark Drive, Cambridge, MA 02140

Phone: 617 221 9059

Last updated: 2024-12-31

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo
Market Cap: Lowest
Employees: Low

TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.

Tags: CNS, autoimmunity, biopharmaceutical, cancer, immunology, infectious disease, rare disease, therapeutics

Symbol: TNXP

Recent Price: $0.36

Industry: Biotechnology

CEO: Dr. Seth Lederman M.D.

Sector: Healthcare

Employees: 103

Address: 26 Main Street, Chatham, NJ 07928

Phone: 862 799 8599

Last updated: 2024-12-31

Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

ZN-c3, ZN-c5

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.

Tags: biopharmaceutical, cancer treatment, clinical trials, small molecule therapeutics

Symbol: ZNTL

Recent Price: $2.92

Industry: Biotechnology

CEO: Dr. Kimberly Lynn Blackwell M.D.

Sector: Healthcare

Employees: 124

Address: 1359 Broadway, New York, NY 10018

Phone: 212 433 3791

Last updated: 2024-12-31

Altimmune, Inc.

Altimmune, Inc. logo
Market Cap: Medium
Employees: Lowest

Pemvidutide

Altimmune, Inc. focuses on developing treatments for obesity and liver diseases with lead product candidate pemvidutide, and Hep Tcell in clinical trials.

Tags: Phase 1b trial, Phase 2 trial, biopharmaceutical, hepatic, liver diseases, obesity

Symbol: ALT

Recent Price: $7.32

Industry: Biotechnology

CEO: Dr. Vipin K. Garg Ph.D.

Sector: Healthcare

Employees: 59

Address: 910 Clopper Road, Gaithersburg, MD 20878

Phone: 240 654 1450

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

CT1812

Cognition Therapeutics is a clinical-stage biopharmaceutical company specializing in small molecule therapeutics for age-related degenerative diseases and central nervous system disorders. Its lead product, CT1812, is designed to treat Alzheimer's disease and dementia with Lewy bodies.

Tags: Alzheimer's disease, biopharmaceutical, central nervous system, retina disorders, small molecule therapeutics

Symbol: CGTX

Recent Price: $0.75

Industry: Biotechnology

CEO: Ms. Lisa Ricciardi

Sector: Healthcare

Employees: 25

Address: 2500 Westchester Avenue, Purchase, NY 10577

Phone: 412 481 2210

Leadership

  • Lisa Ricciardi, Chief Executive Officer​
  • Anthony C. Caggiano, M.D., Ph.D., Chief Medical Officer, Head of R&D
  • John Doyle, Chief Financial Officer
  • Anita Cornet, Head of Quality
  • Theresa Devins, DrPH, Vice President, Clinical Operations
  • Mary Hamby, Ph.D., Vice President, Research
  • Bobby Horn, Corporate Controller
  • Jennifer Iaci, Vice President, Development Operations
  • Steven A. Weissman, Ph.D., Vice President and Head of CMC
  • Jack A. Khattar, CEO
  • Aaron Fletcher, Ph.D.,
  • Brett P. Monia, Ph.D., CEO
  • Ellen B. Richstone,
  • Peggy Wallace,

Last updated: 2024-12-31

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated logo
Market Cap: High
Employees: Medium

Korlym (mifepristone)

Corcept Therapeutics discovers, develops, and commercializes drugs for treating severe metabolic, oncologic, and neuropsychiatric disorders in the United States, including their product Korlym for Cushing's syndrome.

Tags: Cushing's syndrome, biotechnology, neuropsychiatric disorders, oncology, pharmaceuticals

Symbol: CORT

Recent Price: $50.85

Industry: Biotechnology

CEO: Dr. Joseph K. Belanoff M.D.

Sector: Healthcare

Employees: 352

Address: 149 Commonwealth Drive, Menlo Park, CA 94025

Phone: 650 327 3270

Last updated: 2024-12-31

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex

Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.

Tags: gastroenterology, hospital care, oncology, pharmaceutical, prescription products, rheumatology

Symbol: CPIX

Recent Price: $2.42

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. A. J. Kazimi MBA

Sector: Healthcare

Employees: 91

Address: 2525 West End Avenue, Nashville, TN 37203

Phone: 615 255 0068

Last updated: 2024-12-31

eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Tomivosertib

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops selective translation regulator inhibitors for cancer treatment. Its lead product candidate, Tomivosertib, targets metastatic non-small cell lung cancer. The company also has a collaboration with Pfizer Inc. and develops another candidate, Zotatifin, for solid tumors.

Tags: Tomivosertib, Zotatifin, biopharmaceutical, cancer treatment, clinical trials

Symbol: EFTR

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 14

Address: 142 North Cedros Avenue, Solana Beach, CA 92075

Phone: 858 925 8215

Last updated: 2024-12-31

Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. logo
Market Cap: Highest
Employees: Medium

CAPLYTA

Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on developing novel drugs for the treatment of neuropsychiatric and neurologic diseases targeting intracellular signaling in the central nervous system. Key products include CAPLYTA for schizophrenia and ongoing developments in treatments for bipolar depression, autism spectrum disorder, and more.

Tags: biopharmaceutical, bipolar depression, central nervous system, drug development, neurologic diseases, neuropsychiatric, schizophrenia

Symbol: ITCI

Recent Price: $83.48

Industry: Drug Manufacturers - Specialty & Generic

CEO: Dr. Sharon Mates Ph.D.

Sector: Healthcare

Employees: 610

Address: 430 East 29th Street, New York, NY 10016

Phone: 646 440 9333

Leadership

  • Sharon Mates, Ph.D., Chairman, Founder & Chief Executive Officer
  • Michael I. Halstead, J.D., President
  • Mark Neumann, Executive Vice President, Chief Commercial Officer
  • Suresh Durgam, M.D., Executive Vice President, Chief Medical Officer
  • Sanjeev Narula, Executive Vice President, Chief Financial Officer
  • John A. Bardi, Senior Vice President, Market Access, Policy and Government Affairs
  • Robert E. Davis, Ph.D., Senior Vice President, Chief Scientific Officer
  • Karen Sheehy, Esq., Senior Vice President and Chief Compliance Officer
  • Michael Olchaskey, Pharm.D., Senior Vice President, Head of Regulatory Affairs
  • Juan Sanchez, M.D., Vice President of Corporate Communications and Investor Relations
  • Willie R. Earley, M.D., Senior Vice President, Head of Clinical Development
  • Joel S. Marcus, J.D., CPA, Executive Chairman & Founder
  • Rory B. Riggs, MBA, Co-Founder and Director
  • E. Rene Salas, CPA, Former Senior Client Partner at Ernst & Young, LLP; Former CFO, Wellstat, LLC
  • Robert L. Van Nostrand, Chairman, Metabolix; Board Member, Achillion Pharmaceuticals; Former CFO, OSI Pharmaceuticals

Last updated: 2024-12-31

PTC Therapeutics, Inc.

PTC Therapeutics, Inc. logo
Market Cap: High
Employees: Medium

Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi

PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.

Tags: Duchenne muscular dystrophy, biopharmaceutical, medicine development, rare disorders, spinal muscular atrophy

Symbol: PTCT

Recent Price: $45.77

Industry: Biotechnology

CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.

Sector: Healthcare

Employees: 988

Address: 100 Corporate Court, South Plainfield, NJ 07080

Phone: 908 222 7000

Leadership

  • Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
  • Neil Almstead, Ph.D., Chief Technical Operations Officer
  • John Baird, Ph.D., Chief of Staff to the CEO
  • Mark E. Boulding, Executive Vice President and Chief Legal Officer
  • Lee Golden, M.D., Chief Medical Officer
  • Pierre Gravier, Chief Financial Officer
  • Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
  • Linda Montella-Carter, Senior Vice President and Chief Information Officer
  • Eric Pauwels, Chief Business Officer
  • Hege Sollie-Zetlmayer, Chief Human Resources Officer
  • Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
  • Michael Schmertzler, Chairman
  • William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
  • Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
  • Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
  • Emma Reeve, Independent Board Director
  • Mary Smith, The VENG Group
  • David P. Southwell, Former CEO, TScan Therapeutics
  • Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
  • Alethia Young, Chief Financial Officer, Bicycle Therapeutics
  • Jerome B. Zeldis, M.D., Ph.D., Independent Board Director

Last updated: 2024-12-31

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. logo
Market Cap: High
Employees: Medium

Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.

Tags: Crysvita, Dojolvi, Evkeeza, Mepsevii, biopharmaceutical, gene therapy, genetic diseases, rare diseases

Symbol: RARE

Recent Price: $42.27

Industry: Biotechnology

CEO: Dr. Emil D. Kakkis M.D., Ph.D.

Sector: Healthcare

Employees: 1276

Address: 60 Leveroni Court, Novato, CA 94949

Phone: 415 483 8800

Last updated: 2024-12-31

Synaptogenix, Inc.

Synaptogenix, Inc. logo
Market Cap: Lowest
Employees: Lowest

Bryostatin-1

Synaptogenix, Inc. is a biopharmaceutical company focused on developing drug candidates for neurodegenerative diseases, including Alzheimer's disease, using Bryostatin-1.

Tags: Alzheimer's disease, Bryostatin-1, biopharmaceutical, clinical development, neurodegenerative diseases

Symbol: SNPX

Recent Price: $3.37

Industry: Biotechnology

CEO: Dr. Alan J. Tuchman M.D., MBA(FAAN)

Sector: Healthcare

Employees: 5

Address: 1185 Avenue of the Americas, New York, NY 10036

Phone: 973 242 0005

Last updated: 2024-12-31

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

Paltusotine

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing therapeutics for rare endocrine diseases and related tumors. Their leading product candidate, Paltusotine, has completed phase III trials for acromegaly treatment.

Tags: Paltusotine, biotechnology, clinical trials, endocrine diseases, pharmaceutical, therapeutics

Symbol: CRNX

Recent Price: $50.67

Industry: Biotechnology

CEO: Dr. R. Scott Struthers Ph.D.

Sector: Healthcare

Employees: 290

Address: Building No. 2, San Diego, CA 92121

Phone: 858 450 6464

Last updated: 2024-12-31

PaxMedica, Inc. Common Stock

PaxMedica, Inc. Common Stock logo
Market Cap: Lowest
Employees: Lowest

PAX-101

Pax Medica, Inc., is a clinical stage biopharmaceutical company focused on developing anti-purinergic drug therapies for treating intractable neurologic disorders. Their lead product, PAX-101, is an intravenous formulation of suramin for indications such as autism spectrum disorder and chronic fatigue syndrome.

Tags: Autism Treatment, Biopharmaceutical, Chronic Fatigue Syndrome, Drug Development, Neurologic Disorders

Symbol: PXMD

Recent Price: $0.06

Industry: Biotechnology

CEO: Mr. Howard J. Weisman

Sector: Healthcare

Employees: 6

Address: 303 South Broadway, Tarrytown, NY 10591

Phone: 914-987-2876

Last updated: 2024-12-31